Clinical Trials Monitor/
RecruitingNCT03993158

Prospective Cohort Study for Newborns From Patients Treated With ART in Clinical Reproductive Medicine Management System/Electronic Medical Record Cohort Database (CCRM/EMRCD)

Sponsor: The First Affiliated Hospital of Zhengzhou University

Trial Details

ConditionHealth Related
StatusRecruiting
Participants10,000
Est. Completion31 Dec 2050
Last Updated27 May 2026

Primary Outcome

Birth weight; Number of newborns with Congenital malformations

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * All newborns from patients treated with ART in our center. Exclusion Criteria: \-

Trial Sites

Countries

China
View Registry Entry

Related Analysis

Landmark 10,000-Patient Cohort Study Tracks Long-Term Health Outcomes in ART Newborns — 30-Year Follow-Up Data to Guide Clinical Practice

A landmark 30-year prospective cohort study tracking 10,000 ART newborns will provide critical long-term safety data for assisted reproductive technologies. The study monitors birth outcomes and developmental health through 2050.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service